123I-MNI-330

N/A

Report date: 2025/11/24 11:49:06
NME

Base Information

Drug Name123I-MNI-330
Drug Alias Name123I-MNI-330
ClassificationSmall moleculesDiagnostic agent (In vivo)Radiation-emitting products > Radioactive diagnostic agent +[5] 
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMolecular Neuroimaging Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Institute For Neurodegenerative Disorders IncMolecular Neuroimaging Llc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A